Behavioral sensitization to psychostimulants and opioids: What is known in rodents and what still needs to be explored in humans?

Prog Neuropsychopharmacol Biol Psychiatry. 2023 Dec 20:127:110824. doi: 10.1016/j.pnpbp.2023.110824. Epub 2023 Jul 20.

Abstract

Repeated exposure to substances of abuse results in an increase in some behavioral responses. This phenomenon, called behavioral sensitization (BS), is well described in preclinical models. However, its existence in humans is still a matter of debate. After a review of preclinical evidence of BS and its mechanisms in animal models, we reviewed the evidence supporting the existence of BS in humans, despite the limited research available in this regard. We focused our review on opioids and psychostimulants, since they share the ability to promote addictive behaviors. Further, they induce BS despite their distinct sedative and stimulant properties. Moreover, we proposed future research perspectives in this review to address the remaining unsolved questions, especially regarding BS in humans using a harm reduction approach.

Keywords: Behavioral sensitization; Opioids; Psychostimulants.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics, Opioid
  • Animals
  • Behavior, Addictive*
  • Behavior, Animal
  • Central Nervous System Stimulants* / pharmacology
  • Humans
  • Learning
  • Rodentia

Substances

  • Analgesics, Opioid
  • Central Nervous System Stimulants